Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    lesinurad
Show Display Options
RSS Create an RSS feed from your search for:
lesinurad
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Lesinurad Tablet Relative Bioavailability
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg (Site 1);   Drug: Lesinurad 400 mg (Site 2, Lot A);   Drug: Lesinurad 400 mg (Site 2, Lot B)
2 Completed Lesinurad Interaction Study With Ranitidine
Condition: Healthy
Interventions: Drug: lesinurad 400 mg;   Drug: ranitidine 150 mg;   Drug: lesinurad 400 mg + ranitidine 150 mg
3 Completed Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: [14C]lesinurad (100 μg per 10 mL)
4 Completed Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
Condition: Healthy
Interventions: Drug: lesinurad/allopurinol 200/300 FDC tablets;   Drug: lesinurad 200 mg;   Drug: allopurinol 300 mg;   Drug: lesinurad/allopurinol 200/200 FDC tablets;   Drug: allopurinol 200 mg
5 Active, not recruiting Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
Condition: Healthy
Interventions: Drug: lesinurad/allopurinol 200/300 FDC tablet;   Drug: lesinurad 200 mg;   Drug: allopurinol 300 mg
6 Completed Lesinurad Tablet Bioequivalence
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg (manufactured at Site 1);   Drug: Lesinurad 400 mg (manufactured at Site 2)
7 Active, not recruiting Lesinurad and Allopurinol Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: Lesinurad
8 Active, not recruiting Lesinurad and Febuxostat Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
9 Completed Single and Multiple Dose Study in Japanese
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
10 Completed Allopurinol Combination Study
Condition: Gout
Interventions: Drug: RDEA594;   Drug: Placebo;   Drug: Allopurinol
11 Completed
Has Results
Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo;   Drug: Allopurinol
12 Completed
Has Results
Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo;   Drug: Allopurinol
13 Completed Antacid Interaction Study
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: Tums 500 mg and 750 mg;   Drug: MINTOX 10 mL
14 Completed
Has Results
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Condition: Tophaceous Gout
Interventions: Drug: Lesinurad;   Drug: Placebo;   Drug: Febuxostat
15 Completed NSAID Drug Interaction Study
Condition: Gout
Interventions: Drug: lesinurad 400 mg;   Drug: naproxen 250 mg;   Drug: indomethacin 25 mg
16 Completed
Has Results
Open-Label Lesinurad Monotherapy Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
17 Completed
Has Results
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
18 Completed Metformin and Furosemide Drug-Drug Interaction Study
Condition: Healthy
Interventions: Drug: Lesinurad 400 mg;   Drug: Metformin 850 mg;   Drug: Furosemide 40 mg
19 Completed Gout Dose Response Study
Condition: Hyperuricemia
Interventions: Drug: RDEA594;   Drug: Placebo

Indicates status has not been verified in more than two years